ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juniper, E.
Right arrow Articles by King, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juniper, E.
Right arrow Articles by King, D.
Eur Respir J 1999; 14: 32-38
Copyright © ERS Journals Ltd 1999


Original Articles

Development and validation of the Mini Asthma Quality of Life Questionnaire

EF Juniper, GH Guyatt, FM Cox, PJ Ferrie, and DR King

The 32-item Asthma Quality of Life Questionnaire (AQLQ) has shown good responsiveness, reliability and construct validity; properties that are essential for use in clinical trials, clinical practice and surveys. However, to meet the needs of large clinical trials and long-term monitoring, where efficiency may take precedent over precision of measurement, the 15-item self-administered MiniAQLQ has been developed. The MiniAQLQ was tested in a 9-week observational study of 40 adults with symptomatic asthma. Patients completed the MiniAQLQ, the AQLQ, the Short Form (SF)-36, the Asthma Control Questionnaire and spirometry at baseline, 1, 5 and 9 weeks. In patients whose asthma was stable between clinic visits, reliability was very acceptable for the MiniAQLQ (intraclass correlation coefficient (ICC)=0.83), but not quite as good as for the AQLQ (ICC=0.95). Similarly, responsiveness in the MiniAQLQ (p=0.0007) was good but not quite so good as for the AQLQ (p<0.0001). Construct validity (correlation with other indices of health status) was strong for both the MiniAQLQ and the AQLQ. Criterion validity showed that there was no bias between the instruments (p=0.61) and the correlation between them was high (r=0.90). The Mini Asthma Quality of Life Questionnaire has good measurement properties but they are not quite as strong as those of the original Asthma Quality of Life Questionnaire. The choice of questionnaire should depend on the task at hand.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
E. DiMango, J. T. Holbrook, E. Simpson, J. Reibman, J. Richter, S. Narula, N. Prusakowski, J. G. Mastronarde, R. A. Wise, and for the American Lung Association Asthma Clinical
Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on Asthma Severity
Am. J. Respir. Crit. Care Med., November 1, 2009; 180(9): 809 - 816.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
H. Tan, C. Sarawate, J. Singer, K. Elward, R. I. Cohen, B. A. Smart, M. F. Busk, J. Lustig, J. D. O'Brien, and M. Schatz
Impact of Asthma Controller Medications on Clinical, Economic, and Patient-Reported Outcomes
Mayo Clin. Proc., August 1, 2009; 84(8): 675 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The American Lung Association Asthma Clinical Rese
Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma
N. Engl. J. Med., April 9, 2009; 360(15): 1487 - 1499.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Thomas, R K McKinley, S Mellor, G Watkin, E Holloway, J Scullion, D E Shaw, A Wardlaw, D Price, and I Pavord
Breathing exercises for asthma: a randomised controlled trial
Thorax, January 1, 2009; 64(1): 55 - 61.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. D. Campbell, L. Borish, T. Haselkorn, L. Rasouliyan, J. H. Lee, S. E. Wenzel, S. D. Sullivan, and on behalf of the TENOR Study Group
The response to combination therapy treatment regimens in severe/difficult-to-treat asthma
Eur. Respir. J., November 1, 2008; 32(5): 1237 - 1242.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Polley, N. Yaman, L. Heaney, C. Cardwell, E. Murtagh, J. Ramsey, J. MacMahon, R. W. Costello, and L. McGarvey
Impact of Cough Across Different Chronic Respiratory Diseases: Comparison of Two Cough-Specific Health-Related Quality of Life Questionnaires
Chest, August 1, 2008; 134(2): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. A.M. Al-Showair, S. B. Pearson, and H. Chrystyn
The Potential of a 2Tone Trainer To Help Patients Use Their Metered-Dose Inhalers
Chest, June 1, 2007; 131(6): 1776 - 1782.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
The American Lung Association Asthma Clinical Rese
Randomized Comparison of Strategies for Reducing Treatment in Mild Persistent Asthma
N. Engl. J. Med., May 17, 2007; 356(20): 2027 - 2039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
The American Lung Association Asthma Clinical Rese
Clinical Trial of Low-Dose Theophylline and Montelukast in Patients with Poorly Controlled Asthma
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 235 - 242.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. Menzies, A. Nair, P. A. Williamson, S. Schembri, M. Z. H. Al-Khairalla, M. Barnes, T. C. Fardon, L. McFarlane, G. J. Magee, and B. J. Lipworth
Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places.
JAMA, October 11, 2006; 296(14): 1742 - 1748.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. J. Akerman, M. Yaegashi, Z. Khiangte, A. T. Murugan, O. Abe, and J. D. Marmur
Bronchodilator effect of infused B-type natriuretic Peptide in asthma.
Chest, July 1, 2006; 130(1): 66 - 72.
[Abstract] [Full Text] [PDF]


Home page
JSLHRHome page
R. E. Bramlett, A. K. Bothe, and D. M. Franic
Using preference-based measures to assess quality of life in stuttering.
J Speech Lang Hear Res, April 1, 2006; 49(2): 381 - 394.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P.-O. Ehrs, M. Nokela, B. Stallberg, P. Hjemdahl, and E. Wikstrom Jonsson
Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting.
Chest, April 1, 2006; 129(4): 925 - 932.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L.-P. Boulet, C. Lemiere, F. Archambault, G. Carrier, M. C. Descary, and F. Deschesnes
Smoking and Asthma: Clinical and Radiologic Features, Lung Function, and Airway Inflammation
Chest, March 1, 2006; 129(3): 661 - 668.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. Tatis, D. Remache, and E. DiMango
Results of a Culturally Directed Asthma Intervention Program in an Inner-city Latino Community
Chest, September 1, 2005; 128(3): 1163 - 1167.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. K. C. Lee, T. C. Fardon, C. E. Bates, K. Haggart, L. C. McFarlane, and B. J. Lipworth
Airway and Systemic Effects of Hydrofluoroalkane Formulations of High-Dose Ciclesonide and Fluticasone in Moderate Persistent Asthma
Chest, March 1, 2005; 127(3): 851 - 860.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
O. Oguzturk, A. Ekici, M. Kara, M. Ekici, M. Arslan, A. Iteginli, T. Kara, and E. Kurtipek
Psychological Status and Quality of Life in Elderly Patients With Asthma
Psychosomatics, February 1, 2005; 46(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.M. Vignola, F. Paganin, L. Capieu, N. Scichilone, M. Bellia, L. Maakel, V. Bellia, P. Godard, J. Bousquet, and P. Chanez
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD
Eur. Respir. J., December 1, 2004; 24(6): 910 - 917.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
F. A Costa, J. F. van Mil, C. A Duggan, P. L Mata, and M. Caramona
Documentation forms for patients with asthma: an evaluation
Ann. Pharmacother., December 1, 2004; 38(12): 2170 - 2171.
[Full Text] [PDF]


Home page
ChestHome page
B. Mahut, C. Delacourt, F. Zerah-Lancner, J. De Blic, A. Harf, and C. Delclaux
Increase in Alveolar Nitric Oxide in the Presence of Symptoms in Childhood Asthma
Chest, March 1, 2004; 125(3): 1012 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Clin Nurs ResHome page
S. D. Schaffer and L. Tian
Promoting Adherence: Effects of Theory-Based Asthma Education
Clin Nurs Res, February 1, 2004; 13(1): 69 - 89.
[Abstract] [PDF]


Home page
ChestHome page
E. F. Juniper, K. Svensson, A.-C. Mork, and E. Stahl
Measuring Health-Related Quality of Life in Adults During an Acute Asthma Exacerbation
Chest, January 1, 2004; 125(1): 93 - 97.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
H. Pinnock, R. Bawden, S. Proctor, S. Wolfe, J. Scullion, D. Price, and A. Sheikh
Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial
BMJ, March 1, 2003; 326(7387): 477 - 479.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L.-P. Boulet, V. Boulet, and J. Milot
How Should We Quantify Asthma Control?: A Proposal
Chest, December 1, 2002; 122(6): 2217 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E.F. Juniper, G.R. Norman, F.M. Cox, and J.N. Roberts
Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma
Eur. Respir. J., July 1, 2001; 18(1): 38 - 44.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.